Online CME Programs

Faculty/Disclosures
CME Programs › Pain Management and End-of-Life Care › (information) Faculty/Disclosures

Any faculty participating in continuing medical education activities sponsored by the California Society of Anesthesiologists is required to disclose any real or apparent conflict(s) of interest related to the content of their presentation(s) or any of the industry sponsors of the meeting. In addition, speakers must disclose when a product is not labeled for the use under discussion or when a product is still investigational.

Elizabeth Cordes Behringer, M.D. (Author of Module 13)
Anesthesiologist-Intensivist
Department of Anesthesiology
Cedars-Sinai Medical Center, Los Angeles, CA
Clinical Professor of Anesthesiology
University of California, Irvine, Orange, CA

Dr. Behringer has received honoraria for her roles on the Speakers Bureau for LMA North America, and on the Scientific Advisory Board for Sonarmed, Inc.

Jack M. Berger, M.S., M.D., Ph.D. (Module 7)
Associate Professor of Clinical Anesthesiology
Keck School of Medicine
University of Southern California

Dr. Berger has been a speaker and received honoraria from the following companies: Janssen, Purdue, Pfizer, Endo Pharmaceuticals and Abbott Laboratories. None of these affiliations represents a conflict with regard to the content of this article.

Antonio A.F. DeSalles, M.D., Ph.D. (Module 11)
Professor of Neurosurgery
University of California Los Angeles

Dr. DeSalles has disclosed that he has received an honorarium for his role as a speaker for BrainLab and fellowship support for his role as a fellow advisor from BrainLab and Medtronic.

Scott M. Fishman, M.D. (Module 1)
Professor of Anesthesiology
Director of the Division of Pain Medicine
Department of Anesthesiology and Pain Medicine
University of California, Davis School of Medicine
Sacramento, California.

Dr. Fishman has no disclosures to make regarding any real or apparent conflicts of interest.

Ann Lofsky, M.D. (Module 10)
Saint John’s Hospital, Santa Monica

Dr. Lofsky had disclosed that she received a salary from The Doctors Company for her role as a medical consultant.

Sean Mackey, M.D., Ph.D.(Module 9)
Assistant Professor of Anesthesiology and Pain Medicine
Associate Director, Pain Management Division
Stanford University School of Medicine

Dr. Mackey has received speaker fees and honoraria from Pfizer and honoraria from Eli Lilly as a consultant.

Pamela Pierce Palmer, M.D., Ph.D.(Module 3)
Professor, Department of Anesthesia and Perioperative Care, UCSF
Director, UCSF PainCARE-Center for Advanced Research and Education

Dr. Palmer is on the speaker’s bureau for Pfizer, Merck and Medtronic. The article is not biased by her involvement with these companies.

Quynh Pham, M.D.(Module 8)
Program Director
UCLA/VAGLA HS Physical Medicine and
Rehabilitation Resident and Pain Management Fellowship

Dr. Pham has no disclosures to make regarding any real or apparent conflicts of interest.

Joshua P. Prager, M.D., M.S. (Modules 2, 5 and 12)
Director, Center for the Rehabilitation of Pain Syndromes (CRPS)
President, North American Neuromodulation Society (NANS)

Dr. Prager did not receive any support with regard to the preparation of this article. In the last two years, he has performed educational consulting for Medtronic, Advanced Bionics (a Boston Scientific Corporation), Pfizer and Lilly.

Steven Richeimer, M.D. (Module 6)
Associate Professor of Anesthesiology and Psychiatry
Chief of the Division of Pain Medicine, and
Director of Palliative Medicine for the USC/Norris Cancer Center
at University of Southern California, Keck School of Medicine

Dr. Richeimer has received honoraria for speaking from these companies: Janssen, Pfizer and Merck. None of these affiliations represents a conflict with regard to the content of this article.

Mark S. Wallace, M.D. (Module 4)
Associate Professor of Clinical Anesthesiology
Program Director, Center for Pain and Palliative Medicine
University of California San Diego

Dr. Wallace is a consultant for Endo Pharmaceutical, Vertex, Elan Pharmaceutical, and Ono Pharmaceutical. He has received research support from Elan, Renovis, Neurogesx, UCB-Pharma, Allergan and Xenoport. The article is not biased by his association with these companies.

California Society of Anesthesiologists
951 Mariner's Island Boulevard - Suite 270, San Mateo, CA 94404